Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

InterCure Ltd. (INCR) vs Zhengye Biotechnology Holding Limited (ZYBT)

InterCure Ltd. and Zhengye Biotechnology Holding Limited are both Drug Manufacturers Specialty & Generic companies. InterCure Ltd. is the larger, with a market value of $62.3M against $40.1M — 1.6× the size. Across the 5 metrics below, InterCure Ltd. leads on 3 and Zhengye Biotechnology Holding Limited on 2.

Valuation

Metric INCR ZYBT Drug Manufacturers Specialty & Generic median
P/E 9.84 — 20.14
P/S 1.98 — 2.25
P/B 1.96 n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA 23.47 n/m 12.29
EV/Sales 2.12 n/m 2.56
Earnings yield 10.16% — (2.99%)
Free cash flow yield (0.34%) 0.00% 0.00%

Profitability

Metric INCR ZYBT Drug Manufacturers Specialty & Generic median
Gross margin 32.74% — 53.94%
Operating margin 0.00% — 0.00%
Net margin 4.88% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (0.40%)
Return on assets 0.00% 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INCR ZYBT Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 16.15% — 10.01%
EPS growth (last fiscal year) 52.50% (800.00%) —
Revenue growth, 5-year CAGR 31.11% — 6.74%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric INCR ZYBT Drug Manufacturers Specialty & Generic median
Debt to equity 0.27 0.24 0.05
Current ratio 1.85 1.14 2.31
Net debt to EBITDA (4.07) (0.51) 0.85

Dividend

Metric INCR ZYBT Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 — 0.00

Size

Metric INCR ZYBT Drug Manufacturers Specialty & Generic median
Market cap 62.33m 40.13m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack